Ibutamoren vs Anamorelin

Head-to-head comparison of Ibutamoren (Ibutamoren mesylate (MK-677)) and Anamorelin (Anamorelin hydrochloride (ONO-7643)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyIbutamorenAnamorelin
CategoryGrowth HormoneGrowth Hormone
Full NameIbutamoren mesylate (MK-677)Anamorelin hydrochloride (ONO-7643)
Molecular WeightN/AN/A
Half-Lifeabout 24 hoursabout 9 hours
Amino AcidsN/AN/A
Typical Dose10-25 mg/day50 mg/day
RouteOralOral
Purity≥98%≥98%
Studies Count18095
Research StatusClinicalClinical

Ibutamoren Benefits

  • raises GH/IGF-1
  • increases appetite
  • supports lean mass retention
  • oral non-peptide secretagogue

Anamorelin Benefits

  • stimulates appetite
  • raises IGF-1
  • may support weight gain
  • oral dosing

Ibutamoren Dosing

10-25 mg orally once daily|take consistently at the same time each day|monitor fasting glucose and edema in longer studies

Anamorelin Dosing

50 mg orally once daily|often studied with food or per protocol|track weight, appetite, and glucose markers

Ibutamoren Side Effects

  • increased appetite
  • water retention/edema
  • somnolence or lethargy

Anamorelin Side Effects

  • hyperglycemia
  • peripheral edema
  • constipation or nausea

Research Overview

Ibutamoren

Clinical studies show oral ibutamoren reliably elevates GH and IGF-1 over 24 hours with once-daily dosing. Body composition and appetite effects vary by population, and development has been limited by metabolic side effects.

Anamorelin

Trials in cachexia populations showed increased appetite and modest gains in body weight and IGF-1. Regulatory progress has varied by region, but it remains a well-studied ghrelin agonist in the GH space.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Ibutamoren stacks with:

Resistance trainingHigh-protein diet

Anamorelin stacks with:

Nutritional supportResistance training
ghrelin-receptor-agonistgh-secretagogueoralghrelin-agonistcachexia